Filtered By:
Condition: Hives
Therapy: Immunotherapy
This page shows you your search results in order of date.
Order by Relevance | Date
Total 70 results found since Jan 2013.
A Skin Patch Shows Promise in Treating Kids ’ Peanut Allergies
WASHINGTON — An experimental skin patch is showing promise to treat toddlers who are highly allergic to peanuts—training their bodies to handle an accidental bite.
Peanut allergy is one of the most common and dangerous food allergies. Parents of allergic tots are constantly on guard against exposures that can turn birthday parties and play dates into emergency room visits.
There is no cure. The only treatment is for children 4 and older who can consume a special peanut powder to protect against a severe reaction.
The patch, named Viaskin, aims to deliver that kind of treatment through the skin instead. In a maj...
Source: TIME: Health - May 11, 2023 Category: Consumer Health News Authors: LAURAN NEERGAARD—AP Tags: Uncategorized Diet & Nutrition healthscienceclimate wire Source Type: news
Equine allergic skin diseases: Clinical consensus guidelines of the World Association for Veterinary Dermatology
CONCLUSIONS AND CLINICAL RELEVANCE: Insect bite hypersensitivity (IBH) is the best characterised allergic skin disease. An immunoglobulin (Ig)E response against Culicoides salivary antigens is widely documented. Genetics and environmental factors play important roles. Tests with high sensitivity and specificity are lacking, and diagnosis of IBH is based on clinical signs, seasonality and response to insect control. Eosinophils, interleukin (IL)-5 and IL-31 are explored as therapeutic targets. Presently, the most effective treatment is insect avoidance. Existing evidence does not support allergen-specific immunotherapy (ASI...
Source: Veterinary Dermatology - May 8, 2023 Category: Veterinary Research Authors: R Marsella S White V A Fadok D Wilson R Mueller C Outerbridge W Rosenkrantz Source Type: research
Omalizumab and allergen immunotherapy for respiratory allergies: A mini-review from the Allergen-Immunotherapy Committee of the Italian Society of Pediatric Allergy and Immunology (SIAIP)
Allergol Immunopathol (Madr). 2022 Nov 1;50(6):47-52. doi: 10.15586/aei.v50i6.495. eCollection 2022.ABSTRACTAlthough currently approved to treat severe asthma and chronic spontaneous urticaria, omalizumab has also been an effective and safe add-on treatment for other allergic diseases. Namely, omalizumab has been proposed to be used as add-on therapy in patients with allergic rhinitis and asthma and undergoing specific allergen immunotherapy (AIT). AIT is the only treatment that modifies the natural history of IgE-mediated diseases. This brief review summarizes the available evidence and controversies on the efficacy and s...
Source: Allergologia et Immunopathologia - November 6, 2022 Category: Allergy & Immunology Authors: Maria De Filippo Martina Votto Lucia Caminiti Francesco Carella Giovanna De Castro Massimo Landi Roberta Olcese Ilenia Panasiti Mario Vernich Salvatore Barberi Giorgio Ciprandi Gian Luigi Marseglia Source Type: research
